在阿尔茨海默氏病中,对Aβ斑块,神经纤维状结和APOE的明显的转录组反应
Sudeshna Das1,2,3, Zhaozhi Li1,2, Astrid Wachter4
1Neurology Department, Massachusetts General Hospital, Boston, Massachusetts, USA.
概括
阿尔茨海默病的转录学揭示了神经炎症和神经元功能障碍,主要是在粉样质斑块附近. 这些变化由APOE ε4等位基因加剧,影响大脑细胞功能.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 奥米克斯研究表明,在阿尔茨海默病 (AD) 期间,大脑细胞发生了显著的分子变化.
- 这些变化的精确空间分布相对于像粉样斑块和神经纤维状结等AD病理,以及它们与APOE基因型的关联,仍然不完全理解.
研究的目的:
- 为了研究阿尔茨海默病 (AD) 与粉样斑块和神经纤维状结相关的空间转录组景观.
- 阐明APOE基因型对这些空间定义的分子变化的影响.
主要方法:
- 激光捕获微解剖被用于隔离特定区域:粉样β (Aβ) 斑块,斑块周围的50微米光环,神经纤维状结,结周围的50微米光环,以及从两种病理中隔离的远区域 (>50微米).
- 在这些隔离区域上进行了RNA测序,这些区域来自AD和对照捐赠者的皮质.
主要成果:
- 粉样质斑块显示微质基因增加 (神经炎症,细胞化) 和神经元基因减少 (神经传递,能量代谢).
- 神经纤维状结与主要下调的神经元基因有关.
- 观察到分子变化的明显空间梯度:Aβ斑块 > 周围斑块光环 > > 遥远的区域.
- 与APOE ε3载体相比,具有APOE ε4 / ε4基因型的个体表现出更明显的转录基因变异,特别是在粉样斑块区域内.
结论:
- 阿尔茨海默氏症的转录基因变化以神经炎症和神经元功能障碍为特征.
- 这些分子变化主要局限于粉样质斑块周围.
- APOE ε4等位基因加剧了阿尔茨海默病中的这些转录基因变化.
相关概念视频
Alzheimer's Disease: Overview
525
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
525
Alzheimer's Disease: Treatment
219
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
219


